These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 2138248)

  • 41. Mutagenicity of actinomycin D in Neurospora crassa.
    Fisher CR; Malling HV; De Serres FJ; Snyder S
    Mutat Res; 1975 Dec; 33(2-3):187-92. PubMed ID: 55964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic alterations at the molecular level in x-ray induced ad-3B mutants of Neurospora crassa.
    Malling HV; De Serres FJ
    Radiat Res; 1973 Jan; 53(1):77-87. PubMed ID: 4265447
    [No Abstract]   [Full Text] [Related]  

  • 43. Mutagenic activity and specificity of hydrogen peroxide in the ad-3 forward-mutation test in two-component heterokaryons of Neurospora crassa.
    Han JS
    Mutat Res; 1997 Mar; 374(2):169-84. PubMed ID: 9100841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic risk assessment and specific-locus mutations in the ad-3 region of Neurospora crassa.
    de Serres FJ
    Environ Health Perspect; 1994 Jan; 102 Suppl 1(Suppl 1):83-90. PubMed ID: 8187730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Classical and molecular genetic analyses of his-3 mutants of Neurospora crassa. II. Southern blot analyses and molecular mechanisms of mutagenicity.
    Dubins JS; Overton LK; Cobb RR; de Serres FJ
    Mutat Res; 1989 Nov; 215(1):39-47. PubMed ID: 2530448
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutagenesis at the ad-3A and ad-3B loci in haploid UV-sensitive strains of Neurospora crassa. V. Comparison of dose--response curves of single- and double-mutant strains with wild-type.
    Inoue H; Harvey RC; Callen DF; de Serres FJ
    Mutat Res; 1981 Nov; 84(1):49-71. PubMed ID: 6460180
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Learning to "think like a geneticist" with the de Serres ad-3 forward-mutation test in Neurospora crassa.
    Brockman HE
    Mutat Res; 1999 Sep; 437(2):101-4. PubMed ID: 10610427
    [No Abstract]   [Full Text] [Related]  

  • 48. Studies with purple adenine mutants in Neurospora crassa. VI. The effects of differences in genetic background on ad-3A x ad-3B crosses.
    De Serres FJ
    Genetics; 1971 Jul; 68(3):383-400. PubMed ID: 5127402
    [No Abstract]   [Full Text] [Related]  

  • 49. Genetic analysis of the extent and type of functional inactivation in irreparable recessive lethal mutations in the ad-3 region of Neurospora crassa.
    De Serres FJ
    Genetics; 1968 Jan; 58(1):69-77. PubMed ID: 5656344
    [No Abstract]   [Full Text] [Related]  

  • 50. The mutation SK(ad-3A) cancels the dominance of ad-3A+ over ad-3A in the ascus of Neurospora.
    Delange AM
    Genetics; 1981 Feb; 97(2):237-46. PubMed ID: 6456169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic analysis of adenine-3 mutants induced by hycanthone, lucanthone and their indazole analogs in Neurospora crassa.
    Ong T; de Serres FJ
    J Environ Pathol Toxicol; 1980 Nov; 4(5-6):1-8. PubMed ID: 6452485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ionizing radiation-induced mutagenesis: radiation studies in Neurospora predictive for results in mammalian cells.
    Evans HH; DeMarini DM
    Mutat Res; 1999 Sep; 437(2):135-50. PubMed ID: 10556618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A recessive circadian clock mutation at the frq locus of Neurospora crassa.
    Loros JJ; Richman A; Feldman JF
    Genetics; 1986 Dec; 114(4):1095-110. PubMed ID: 2948874
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Azaguanine-resistant mutants induced by several mutagens in a neurospora heterokaryon.
    Hoffmann GR; Malling HV
    Mutat Res; 1975 Mar; 27(3):307-18. PubMed ID: 163959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two N-hydroxylaminopurines are highly mutagenic in the ad-3 forward-mutation test in growing cultures of heterokaryon 12 of Neurospora crassa.
    Brockman HE; de Serres FJ; Ong TM; Hung CY
    Mutat Res; 1987 Mar; 177(1):61-75. PubMed ID: 2950320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of Neurospora in the evaluation of the mutagenic activity of environmental chemicals.
    de Serres FJ
    Environ Mutagen; 1983; 5(3):341-51. PubMed ID: 6221926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neurospora crassa A mating-type region.
    Glass NL; Grotelueschen J; Metzenberg RL
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):4912-6. PubMed ID: 2142303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutagenicity and mutagenic specificity of metronidazole and niridazole in Neurospora crassa.
    Ong T; Slade B; de Serres FJ
    J Environ Pathol Toxicol; 1979; 2(4):1109-18. PubMed ID: 156240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of the uvs-2 allele of Neurospora crassa on the mutagenic potency of two N-hydroxylaminopurines and 2-aminopurine in the ad-3 forward-mutation test.
    Brockman HE; de Serres FJ; Hung CY; Ong T
    Mutat Res; 1989 Jul; 218(1):1-11. PubMed ID: 2526296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The size distribution of x-ray induced multilocus deletions in the ad-3 region of Neurospora crassa.
    De Serres FJ; Webber BB
    Genetics; 1967 Oct; 57(2):449-54. PubMed ID: 5584575
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.